详细说明
- Purity>85%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
- Endotoxin Level<0.10 EU per 1 μg of the protein by the LAL method.
- ActivityMeasured by its ability to inhibit the cell growth of DU145 human prostate carcinoma cells. Miyazaki, H. et al. (2004) Oncogene 23:9326. The ED 50 for this effect is 0.7-3.5 μg/mL.
- SourceChinese Hamster Ovary cell line, CHO-derived Ala264-His402
- Accession #
- N-terminal Sequence
AnalysisAla264 - Structure / FormDisulfide-linked homodimer
- Predicted Molecular Mass16 kDa
- SDS-PAGE17-20 kDa, reducing conditions
9316-BP | | |
Formulation Lyophilized from a 0.2 μm filtered solution in HCl. | ||
Reconstitution Reconstitute at 250 μg/mL in 4 mM HCl. | ||
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. | ||
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
- References:
- Ozkaynak, E. et al. (1992) J. Biol. Chem. 267:25220.
- Chen, D. et al. (2004) Growth Factors 22:233.
- Bragdon, B. et al. (2010) Cell Signal. Oct 16 epub.
- Singh, A. and R.J. Morris (2010) Cytokine Growth Factor Rev. 21:299.
- Zhao, G.-Q. and B.L. Hogan (1996) Mech. Dev. 57:159.
- Ying, Y. and G.-Q. Zhao (2000) Biol. Reprod. 63:1781.
- Zhao, G.-Q. et al. (1998) Development 125:1103.
- Zhao, G.-Q. et al. (2001) Dev. Biol. 240:212.
- Zhao, G.-Q. et al. (1998) Genes Dev. 10:1657.
- van der Horst, G. et al. (2002) Bone 31:661.
- Cho, T.-J. et al. (2002) J. Bone Miner. Res. 17:513.
- Paic, F. et al. (2009) Bone 45:682.
- Sulzbacher, I. et al. (2002) J. Clin. Pathol. 55:381.
- Cheng, Z. et al. (2014) Oncol. Rep. 32:1861.
- Whittle, A.J. et al. (2012) Cell 149:871.
- Martins, L. et al. (2016) Cell Rep. 16:2231.
- Long Name:Bone Morphogenetic Protein 8b
- Entrez Gene IDs:656 (Human); 12164 (Mouse)
- Alternate Names:BMP-8; BMP-8b; bone morphogenetic protein 8b; MGC131757; OP-3